scholarly journals Atmospheric extinction in solar tower plants: absorption and broadband correction for MOR measurements

2015 ◽  
Vol 8 (8) ◽  
pp. 3467-3480 ◽  
Author(s):  
N. Hanrieder ◽  
S. Wilbert ◽  
R. Pitz-Paal ◽  
C. Emde ◽  
J. Gasteiger ◽  
...  
Keyword(s):  
Light Source ◽  
Solar Spectrum ◽  
Mean Difference ◽  
Infrared Light ◽  
Atmospheric Extinction ◽  
Atmospheric Scattering ◽  
Radiation Losses ◽  
Direct Normal Irradiance ◽  
The Mean ◽  
Sun Photometer

Abstract. Losses of reflected Direct Normal Irradiance due to atmospheric extinction in concentrated solar tower plants can vary significantly with site and time. The losses of the direct normal irradiance between the heliostat field and receiver in a solar tower plant are mainly caused by atmospheric scattering and absorption by aerosol and water vapor concentration in the atmospheric boundary layer. Due to a high aerosol particle number, radiation losses can be significantly larger in desert environments compared to the standard atmospheric conditions which are usually considered in ray-tracing or plant optimization tools. Information about on-site atmospheric extinction is only rarely available. To measure these radiation losses, two different commercially available instruments were tested, and more than 19 months of measurements were collected and compared at the Plataforma Solar de Almería. Both instruments are primarily used to determine the meteorological optical range (MOR). The Vaisala FS11 scatterometer is based on a monochromatic near-infrared light source emission and measures the strength of scattering processes in a small air volume mainly caused by aerosol particles. The Optec LPV4 long-path visibility transmissometer determines the monochromatic attenuation between a light-emitting diode (LED) light source at 532 nm and a receiver and therefore also accounts for absorption processes. As the broadband solar attenuation is of interest for solar resource assessment for concentrated solar power (CSP), a correction procedure for these two instruments is developed and tested. This procedure includes a spectral correction of both instruments from monochromatic to broadband attenuation. That means the attenuation is corrected for the time-dependent solar spectrum which is reflected by the collector. Further, an absorption correction for the Vaisala FS11 scatterometer is implemented. To optimize the absorption and broadband correction (ABC) procedure, additional measurement input of a nearby sun photometer is used to enhance on-site atmospheric assumptions for description of the atmosphere in the algorithm. Comparing both uncorrected and spectral- and absorption-corrected extinction data from 1-year measurements at the Plataforma Solar de Almería, the mean difference between the scatterometer and the transmissometer is reduced from 4.4 to 0.57 %. Applying the ABC procedure without the usage of additional input data from a sun photometer still reduces the difference between both sensors to about 0.8 %. Applying an expert guess assuming a standard aerosol profile for continental regions instead of additional sun photometer input results in a mean difference of 0.8 %. Additionally, a simulation approach which just uses sun photometer and common meteorological data to determine the on-site atmospheric extinction at surface is presented and corrected FS11 and LPV4 measurements are validated with the simulation results. For T1 km equal to 0.9 and a 10 min time resolution, an uncertainty analysis showed that an absolute uncertainty of about 0.038 is expected for the FS11 and about 0.057 for the LPV4. Combining both uncertainties results in an overall absolute uncertainty of 0.068 which justifies quite well the mean RMSE between both corrected data sets. For yearly averages several error influences average out and absolute uncertainties of 0.020 and 0.054 can be expected for the FS11 and the LPV4, respectively. Therefore, applying this new correction method, both instruments can now be utilized to sufficiently accurately determine the solar broadband extinction in tower plants.

scholarly journals Atmospheric extinction in solar tower plants: the Absorption and Broadband Correction for MOR measurements

2015 ◽  
Vol 8 (5) ◽  
pp. 4737-4768
Author(s):  
N. Hanrieder ◽  
S. Wilbert ◽  
R. Pitz-Paal ◽  
C. Emde ◽  
J. Gasteiger ◽  
...  
Keyword(s):  
Light Source ◽  
Solar Spectrum ◽  
Mean Difference ◽  
Infrared Light ◽  
Vapor Concentration ◽  
Atmospheric Extinction ◽  
Atmospheric Scattering ◽  
Radiation Losses ◽  
Direct Normal Irradiance ◽  
Sun Photometer

Abstract. Losses of reflected Direct Normal Irradiance due to atmospheric extinction in concentrating solar tower plants can vary significantly with site and time. The losses of the direct normal irradiance between the heliostat field and receiver in a solar tower plant are mainly caused by atmospheric scattering and absorption by aerosol and water vapor concentration in the atmospheric boundary layer. Due to a high aerosol particle number, radiation losses can be significantly larger in desert environments compared to the standard atmospheric conditions which are usually considered in raytracing or plant optimization tools. Information about on-site atmospheric extinction is only rarely available. To measure these radiation losses, two different commercially available instruments were tested and more than 19 months of measurements were collected at the Plataforma Solar de Almería and compared. Both instruments are primarily used to determine the meteorological optical range (MOR). The Vaisala FS11 scatterometer is based on a monochromatic near-infrared light source emission and measures the strength of scattering processes in a small air volume mainly caused by aerosol particles. The Optec LPV4 long-path visibility transmissometer determines the monochromatic attenuation between a light-emitting diode (LED) light source at 532 nm and a receiver and therefore also accounts for absorption processes. As the broadband solar attenuation is of interest for solar resource assessment for Concentrating Solar Power (CSP), a correction procedure for these two instruments is developed and tested. This procedure includes a spectral correction of both instruments from monochromatic to broadband attenuation. That means the attenuation is corrected for the actual, time-dependent by the collector reflected solar spectrum. Further, an absorption correction for the Vaisala FS11 scatterometer is implemented. To optimize the Absorption and Broadband Correction (ABC) procedure, additional measurement input of a nearby sun photometer is used to enhance on-site atmospheric assumptions for description of the atmosphere in the algorithm. Comparing both uncorrected and spectral- and absorption-corrected extinction data from one year measurements at the Plataforma Solar de Almería, the mean difference between the scatterometer and the transmissometer is reduced from 4.4 to 0.6%. Applying the ABC procedure without the usage of additional input data from a sun photometer still reduces the difference between both sensors to about 0.8%. Applying an expert guess assuming a standard aerosol profile for continental regions instead of additional sun photometer input results in a mean difference of 0.81%. Therefore, applying this new correction method, both instruments can now be utilized to determine the solar broadband extinction in tower plants sufficiently accurate.

scholarly journals Do we need to improve the reporting of evidence in tendinopathy management? A critical appraisal of systematic reviews with recommendations on strength of evidence assessment

2021 ◽  
Vol 7 (1) ◽  
pp. e000920
Author(s):  
Dimitris Challoumas ◽  
Neal L Millar
Keyword(s):  
Systematic Reviews ◽  
Assessment Tool ◽  
Data Extraction ◽  
Cochrane Collaboration ◽  
Mean Difference ◽  
Strength Of Evidence ◽  
The Mean ◽  
Randomised Controlled ◽  
Meta Analyses ◽  
The Cochrane Collaboration

ObjectiveTo critically appraise the quality of published systematic reviews (SRs) of randomised controlled trials (RCTs) in tendinopathy with regard to handling and reporting of results with special emphasis on strength of evidence assessment.Data sourcesMedline from inception to June 2020.Study eligibilityAll SRs of RCTs assessing the effectiveness of any intervention(s) on any location of tendinopathy.Data extraction and synthesisIncluded SRs were appraised with the use of a 12-item tool devised by the authors arising from the Preferred Reporting Items in Systematic Reviews and Meta-Analyses statement and other relevant guidance. Subgroup analyses were performed based on impact factor (IF) of publishing journals and date of publication.ResultsA total of 57 SRs were included published in 38 journals between 2006 and 2020. The most commonly used risk-of-bias (RoB) assessment tool and strength of evidence assessment tool were the Cochrane Collaboration RoB tool and the Cochrane Collaboration Back Review Group tool, respectively. The mean score on the appraisal tool was 46.5% (range 0%–100%). SRs published in higher IF journals (>4.7) were associated with a higher mean score than those in lower IF journals (mean difference 26.4%±8.8%, p=0.004). The mean score of the 10 most recently published SRs was similar to that of the first 10 published SRs (mean difference 8.3%±13.7%, p=0.54). Only 23 SRs (40%) used the results of their RoB assessment in data synthesis and more than half (n=30; 50%) did not assess the strength of evidence of their results. Only 12 SRs (21%) assessed their strength of evidence appropriately.ConclusionsIn light of the poor presentation of evidence identified by our review, we provide recommendations to increase transparency and reproducibility in future SRs.

scholarly journals The Sankara Nethralaya Tamil Nadu Essilor Myopia (STEM) Study—Defining a Threshold for Non-Cycloplegic Myopia Prevalence in Children

2021 ◽  
Vol 10 (6) ◽  
pp. 1215
Author(s):  
Aparna Gopalakrishnan ◽  
Jameel Rizwana Hussaindeen ◽  
Viswanathan Sivaraman ◽  
Meenakshi Swaminathan ◽  
Yee Ling Wong ◽  
...  
Keyword(s):  
Open Field ◽  
Tamil Nadu ◽  
Mean Difference ◽  
School Vision ◽  
Elite School ◽  
Prevalence Estimates ◽  
The Mean ◽  
Clinically Significant ◽  
Set Up ◽  
Definition Of

The aim of this study was to investigate the agreement between cycloplegic and non-cycloplegic autorefraction with an open-field auto refractor in a school vision screening set up, and to define a threshold for myopia that agrees with the standard cycloplegic refraction threshold. The study was conducted as part of the Sankara Nethralaya Tamil Nadu Essilor Myopia (STEM) study, which investigated the prevalence, incidence, and risk factors for myopia among children in South India. Children from two schools aged 5 to 15 years, with no ocular abnormalities and whose parents gave informed consent for cycloplegic refraction were included in the study. All the children underwent visual acuity assessment (Pocket Vision Screener, Elite school of Optometry, India), followed by non-cycloplegic and cycloplegic (1% tropicamide) open-field autorefraction (Grand Seiko, WAM-5500). A total of 387 children were included in the study, of whom 201 were boys. The mean (SD) age of the children was 12.2 (±2.1) years. Overall, the mean difference between cycloplegic and non-cycloplegic spherical equivalent (SE) open-field autorefraction measures was 0.34 D (limits of agreement (LOA), 1.06 D to −0.38 D). For myopes, the mean difference between cycloplegic and non-cycloplegic SE was 0.13 D (LOA, 0.63D to −0.36D). The prevalence of myopia was 12% (95% CI, 8% to 15%) using the threshold of cycloplegic SE ≤ −0.50 D, and was 14% (95% CI, 11% to 17%) with SE ≤ −0.50 D using non-cycloplegic refraction. When myopia was defined as SE of ≤−0.75 D under non-cycloplegic conditions, there was no difference between cycloplegic and non-cycloplegic open-field autorefraction prevalence estimates (12%; 95% CI, 8% to 15%; p = 1.00). Overall, non-cycloplegic refraction underestimates hyperopia and overestimates myopia; but for subjects with myopia, this difference is minimal and not clinically significant. A threshold of SE ≤ −0.75 D agrees well for the estimation of myopia prevalence among children when using non-cycloplegic refraction and is comparable with the standard definition of cycloplegic myopic refraction of SE ≤ −0.50 D.

scholarly journals Estimates of the mean difference in orthopaedic randomized trials: obligatory yet obscure

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Lauri Raittio ◽  
Antti Launonen ◽  
Ville M. Mattila ◽  
Aleksi Reito
Keyword(s):  
Primary Outcome ◽  
Outcome Measure ◽  
Patient Reported Outcome ◽  
Ceiling Effect ◽  
Mean Difference ◽  
Discussion Section ◽  
Power Calculations ◽  
Randomized Controlled ◽  
Patient Reported ◽  
The Mean

Abstract Background Randomized controlled trials in orthopaedics are powered to mainly find large effect sizes. A possible discrepancy between the estimated and the real mean difference is a challenge for statistical inference based on p-values. We explored the justifications of the mean difference estimates used in power calculations. The assessment of distribution of observations in the primary outcome and the possibility of ceiling effects were also assessed. Methods Systematic review of the randomized controlled trials with power calculations in eight clinical orthopaedic journals published between 2016 and 2019. Trials with one continuous primary outcome and 1:1 allocation were eligible. Rationales and references for the mean difference estimate were recorded from the Methods sections. The possibility of ceiling effect was addressed by the assessment of the weighted mean and standard deviation of the primary outcome and its elaboration in the Discussion section of each RCT where available. Results 264 trials were included in this study. Of these, 108 (41 %) trials provided some rationale or reference for the mean difference estimate. The most common rationales or references for the estimate of mean difference were minimal clinical important difference (16 %), observational studies on the same subject (8 %) and the ‘clinical relevance’ of the authors (6 %). In a third of the trials, the weighted mean plus 1 standard deviation of the primary outcome reached over the best value in the patient-reported outcome measure scale, indicating the possibility of ceiling effect in the outcome. Conclusions The chosen mean difference estimates in power calculations are rarely properly justified in orthopaedic trials. In general, trials with a patient-reported outcome measure as the primary outcome do not assess or report the possibility of the ceiling effect in the primary outcome or elaborate further in the Discussion section.

scholarly journals Corneal Biomechanical Parameters and Central Corneal Thickness in Glaucoma Patients, Glaucoma Suspects, and a Healthy Population

2021 ◽  
Vol 10 (12) ◽  
pp. 2637
Author(s):  
Mª. Ángeles del Buey-Sayas ◽  
Elena Lanchares-Sancho ◽  
Pilar Campins-Falcó ◽  
María Dolores Pinazo-Durán ◽  
Cristina Peris-Martínez
Keyword(s):  
Central Corneal Thickness ◽  
Corneal Thickness ◽  
Mean Difference ◽  
The Other ◽  
Control Group ◽  
Healthy Population ◽  
Diagnostic Categories ◽  
Significant Difference ◽  
Biomechanical Parameters ◽  
The Mean

Purpose: To evaluate and compare corneal hysteresis (CH), corneal resistance factor (CRF), and central corneal thickness (CCT), measurements were taken between a healthy population (controls), patients diagnosed with glaucoma (DG), and glaucoma suspect patients due to ocular hypertension (OHT), family history of glaucoma (FHG), or glaucoma-like optic discs (GLD). Additionally, Goldmann-correlated intraocular pressure (IOPg) and corneal-compensated IOP (IOPcc) were compared between the different groups of patients. Methods: In this prospective analytical-observational study, a total of 1065 patients (one eye of each) were recruited to undergo Ocular Response Analyzer (ORA) testing, ultrasound pachymetry, and clinical examination. Corneal biomechanical parameters (CH, CRF), CCT, IOPg, and IOPcc were measured in the control group (n = 574) and the other groups: DG (n = 147), FHG (n = 78), GLD (n = 90), and OHT (n = 176). We performed a variance analysis (ANOVA) for all the dependent variables according to the different diagnostic categories with multiple comparisons to identify the differences between the diagnostic categories, deeming p < 0.05 as statistically significant. Results: The mean CH in the DG group (9.69 mmHg) was significantly lower compared to controls (10.75 mmHg; mean difference 1.05, p < 0.001), FHG (10.70 mmHg; mean difference 1.00, p < 0.05), GLD (10.63 mmHg; mean difference 0.93, p < 0.05) and OHT (10.54 mmHg; mean difference 0.84, p < 0.05). No glaucoma suspects (FHG, GLD, OHT groups) presented significant differences between themselves and the control group (p = 1.00). No statistically significant differences were found in the mean CRF between DG (11.18 mmHg) and the control group (10.75 mmHg; mean difference 0.42, p = 0.40). The FHG and OHT groups showed significantly higher mean CRF values (12.32 and 12.41 mmHg, respectively) than the DG group (11.18 mmHg), with mean differences of 1.13 (p < 0.05) and 1.22 (p < 0.001), respectively. No statistically significant differences were found in CCT in the analysis between DG (562 μ) and the other groups (control = 556 μ, FHG = 576 μ, GLD = 569 μ, OHT = 570 μ). The means of IOPg and IOPcc values were higher in the DG patient and suspect groups than in the control group, with statistically significant differences in all groups (p < 0.001). Conclusion: This study presents corneal biomechanical values (CH, CRF), CCT, IOPg, and IOPcc for diagnosed glaucoma patients, three suspected glaucoma groups, and a healthy population, using the ORA. Mean CH values were markedly lower in the DG group (diagnosed with glaucoma damage) compared to the other groups. No significant difference was found in CCT between the DG and control groups. Unexpectedly, CRF showed higher values in all groups than in the control group, but the difference was only statistically significant in the suspect groups (FHG, GLD, and OHT), not in the DG group.

scholarly journals A Side-Absorption Concentrated Module with a Diffractive Optical Element as a Spectral-Beam-Splitter for a Hybrid-Collecting Solar System

Energies ◽  
2020 ◽  
Vol 13 (1) ◽  
pp. 192
Author(s):  
An-Chi Wei ◽  
Wei-Jie Chang ◽  
Jyh-Rou Sze
Keyword(s):  
Fill Factor ◽  
Beam Splitter ◽  
Light Guide ◽  
Solar Spectrum ◽  
Optical Element ◽  
Grating Period ◽  
Infrared Light ◽  
Solar Systems ◽  
Module Efficiency ◽  
Energy Conversion Devices

In this paper, we propose a side-absorption concentrated module with diffractive grating as a spectral-beam-splitter to divide sunlight into visible and infrared parts. The separate solar energy can be applied to different energy conversion devices or diverse applications, such as hybrid PV/T solar systems and other hybrid-collecting solar systems. Via the optimization of the geometric parameters of the diffractive grating, such as the grating period and height, the visible and the infrared bands can dominate the first and the zeroth diffraction orders, respectively. The designed grating integrated with the lens and the light-guide forms the proposed module, which is able to export visible and infrared light individually. This module is demonstrated in the form of an array consisting of seven units, successfully out-coupling the spectral-split beams by separate planar ports. Considering the whole solar spectrum, the simulated and measured module efficiencies of this module were 45.2% and 34.8%, respectively. Analyses of the efficiency loss indicated that the improvement of the module efficiency lies in the high fill-factor lens array, the high-reflectance coating, and less scattering.

A New Equal Area Method to Calculate and Represent Physiologic, Anatomical, and Alveolar Dead Spaces

2006 ◽  
Vol 104 (4) ◽  
pp. 696-700 ◽  
Author(s):  
Yongquan Tang ◽  
Martin J. Turner ◽  
A Barry Baker
Keyword(s):  
Carbon Dioxide ◽  
Dead Space ◽  
Graphical Method ◽  
Mean Difference ◽  
Equal Area ◽  
Area Method ◽  
Physiologic Dead Space ◽  
Anatomical Dead Space ◽  
The Mean ◽  
The Difference

Background Physiologic dead space is usually estimated by the Bohr-Enghoff equation or the Fletcher method. Alveolar dead space is calculated as the difference between anatomical dead space estimated by the Fowler equal area method and physiologic dead space. This study introduces a graphical method that uses similar principles for measuring and displaying anatomical, physiologic, and alveolar dead spaces. Methods A new graphical equal area method for estimating physiologic dead space is derived. Physiologic dead spaces of 1,200 carbon dioxide expirograms obtained from 10 ventilated patients were calculated by the Bohr-Enghoff equation, the Fletcher area method, and the new graphical equal area method and were compared by Bland-Altman analysis. Dead space was varied by varying tidal volume, end-expiratory pressure, inspiratory-to-expiratory ratio, and inspiratory hold in each patient. Results The new graphical equal area method for calculating physiologic dead space is shown analytically to be identical to the Bohr-Enghoff calculation. The mean difference (limits of agreement) between the physiologic dead spaces calculated by the new equal area method and Bohr-Enghoff equation was -0.07 ml (-1.27 to 1.13 ml). The mean difference between new equal area method and the Fletcher area method was -0.09 ml (-1.52 to 1.34 ml). Conclusions The authors' equal area method for calculating, displaying, and visualizing physiologic dead space is easy to understand and yields the same results as the classic Bohr-Enghoff equation and Fletcher area method. All three dead spaces--physiologic, anatomical, and alveolar--together with their relations to expired volume, can be displayed conveniently on the x-axis of a carbon dioxide expirogram.

scholarly journals Photothermal Therapy Using Gold Nanorods and Near-Infrared Light in a Murine Melanoma Model Increases Survival and Decreases Tumor Volume

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Mary K. Popp ◽  
Imane Oubou ◽  
Colin Shepherd ◽  
Zachary Nager ◽  
Courtney Anderson ◽  
...  
Keyword(s):  
Light Source ◽  
Gold Nanorods ◽  
Photothermal Therapy ◽  
Near Infrared ◽  
Tumor Volume ◽  
Infrared Light ◽  
Led Light ◽  
Murine Melanoma ◽  
Nir Light ◽  
Melanoma Model

Photothermal therapy (PTT) treatments have shown strong potential in treating tumors through their ability to target destructive heat preferentially to tumor regions. In this paper we demonstrate that PTT in a murine melanoma model using gold nanorods (GNRs) and near-infrared (NIR) light decreases tumor volume and increases animal survival to an extent that is comparable to the current generation of melanoma drugs. GNRs, in particular, have shown a strong ability to reach ablative temperatures quickly in tumors when exposed to NIR light. The current research tests the efficacy of GNRs PTT in a difficult and fast growing murine melanoma model using a NIR light-emitting diode (LED) light source. LED light sources in the NIR spectrum could provide a safer and more practical approach to photothermal therapy than lasers. We also show that the LED light source can effectively and quickly heatin vitroandin vivomodels to ablative temperatures when combined with GNRs. We anticipate that this approach could have significant implications for human cancer therapy.

scholarly journals Effect of Hope-oriented group counseling on mental health of infertile women with failed IVF cycles: a randomized controlled trial

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Roya Rahimi ◽  
Shirin Hasanpour ◽  
Mojgan. Mirghafourvand ◽  
Khalil Esmaeilpour
Keyword(s):  
Mental Health ◽  
Confidence Interval ◽  
Group Counseling ◽  
Controlled Trial ◽  
Intervention Group ◽  
Mean Difference ◽  
Control Group ◽  
The Mean ◽  
And Control

Abstract Background Considering the prevalence of infertility in the community and the consequences of failure of infertility treatments on women’s mental health, interventions that can control stress, anxiety and depression in infertile women with a history of IVF failure will be very helpful. This study aimed to determine the effects of hope-oriented group counseling on mental health (primary outcome) and quality of life (QoL) (secondary outcome) of women with failed IVF cycles. Method This randomized controlled trial was conducted on 60 women with failed IVF cycles visiting Infertility Clinic at Al-Zahra Teaching Hospital of Tabriz- Iran. Participants were allocated to the intervention group (n = 30) and control group (n = 30) based on a randomized block design. Hope-oriented group counseling was provided to the intervention group in six 45–60 min sessions (once a week). The control group only received routine care to undergo another IVF cycle. The Depression Anxiety Stress Scale-21 (DASS-21) and the SF-12 Quality of Life Scale were filled out by interviewing the participants before the intervention and one week and one month after the intervention. After intervention 26 participants in each group were included in the analysis. Results There was no significant difference between the intervention and control groups in the socio-demographic profile of participants (P > 0.05). The post-intervention mean score of stress (adjusted mean difference = − 1.7, 95% confidence interval: − 3.2 to − 0.3, P = 0.018) and depression (adjusted mean difference = − 1.3, 95% confidence interval: − 4.7 to − 1.5, P < 0.001) was significantly lower in the intervention group compared to the control. Although the mean anxiety score was lower in the intervention group compared to the control, the difference between them was not statistically significant (adjusted mean difference = − 1.1, 95% confidence interval: − 2.6 to 0.4, P = 0.153). The mean score of QoL was significantly higher in the intervention group than that of the control group (adjusted mean difference = 6.9, 95% confidence interval: 5.1 to 8.8, P < 0.001). Conclusion Hope-oriented group counseling was effective in reducing stress and depression and improving QoL in women with failed IVF cycles. It is recommended to use this counseling approach, along with other methods, to improve the mental health of women with failed IVF cycles. Trial registration TCT Registration Number: TCTR 20191017003, registered on October 17, 2019.

Sign in / Sign up

Export Citation Format

Share Document